Sawai Pharmaceutical Company Limited This website provides information regarding Sawai Pharmaceutical Company Limited, a Japanese leading generic drug manufacturer. Sun, 31 Mar 2019 23:46:48 +0000 ja hourly 1 UPSHER-SMITH LAUNCHES GENERIC VERSION OF PROZAC® (FLUOXETINE) TABLETS https://www.sawai.co.jp/en/file/2019/03/20190328-02.pdf Thu, 28 Mar 2019 10:03:34 +0000 MHLW Approves New Indication for DONEPEZIL Tablets, OD Tablets and Fine Granules https://www.sawai.co.jp/en/file/2019/03/20190327-02.pdf Wed, 27 Mar 2019 13:38:09 +0000 MHLW Approves New Indication for ARIPIPRAZOLE Tablets and Oral Solution https://www.sawai.co.jp/en/file/2019/03/20190306-02.pdf Wed, 06 Mar 2019 11:08:25 +0000 Upsher-Smith Laboratories, LLC celebrates its 100-year anniversary. https://www.sawai.co.jphttps://www.upsher-smith.com/about-us/celebrating-our-centennial/ Wed, 20 Feb 2019 09:53:38 +0000 Sawai Receives Approvals for Three Generic Drugs with Six Strengths https://www.sawai.co.jp/en/file/2019/02/20190215-02.pdf Fri, 15 Feb 2019 12:06:25 +0000 Sawai Reports Third Quarter FY2018 Financial Results https://www.sawai.co.jphttps://www.sawai.co.jp/en/ir/library/materials/ Thu, 14 Feb 2019 15:08:36 +0000 An interview with Mitsuo Sawai (President of Sawai Pharmaceutical Co., Ltd.) was published in 2019 Japan Business Report in the South China Morning Post. https://www.sawai.co.jphttps://www.scmp.com/country-reports/country-reports/topics/japan-business-report-feb-2019/article/2184208/sawai Wed, 13 Feb 2019 13:02:02 +0000 MHLW Approves New Indication for ARGATROBAN Injection https://www.sawai.co.jp/en/file/2019/01/20190109-02.pdf Wed, 09 Jan 2019 11:19:14 +0000 Sawai Launches Six Generic Drugs with 14 Strengths https://www.sawai.co.jp/en/file/2018/12/20181213-02.pdf Thu, 13 Dec 2018 14:08:40 +0000 MHLW Approves New Indication for RISEDRONATE Tablets and DOBUTAMINE I.V. Infusion https://www.sawai.co.jp/en/file/2018/12/20181205-03.pdf Wed, 05 Dec 2018 11:10:58 +0000 MHLW Approves New Indication for LEVOFOLINATE I.V. Infusion https://www.sawai.co.jp/en/file/2018/11/20181121-02.pdf Wed, 21 Nov 2018 15:30:30 +0000 IR “Summary of Financial Results for the 1st Half of FY2018” https://www.sawai.co.jphttp://v4.eir-parts.net/v4Contents/View.aspx?template=ir_material_for_fiscal_ym&sid=55858&code=4555 Wed, 14 Nov 2018 15:12:20 +0000 IR “Financial Results for the 1st Half of FY 2018” https://www.sawai.co.jphttp://v4.eir-parts.net/v4Contents/View.aspx?template=ir_material_for_fiscal_ym&sid=55857&code=4555 Wed, 14 Nov 2018 15:11:22 +0000 Upsher-Smith Launches Generic Version of ONFI® (Clobazam), CIV In Tablet And Oral Suspension Dosage Forms https://www.sawai.co.jp/en/file/2018/10/20181024-03.pdf Wed, 24 Oct 2018 14:51:27 +0000 Sawai Pharmaceutical Receives Public Knowledge-Based Applications for Anti-Cancer Agent OXALIPLATIN I.V. Infusion Solution for Additional Indication https://www.sawai.co.jp/en/file/2018/09/20180921-02.pdf Fri, 21 Sep 2018 13:10:02 +0000 MHLW Approves New Indication for ARIPIPRAZOLE Tablets 3 mg / 6 mg / 12 mg / 24mg [SAWAI] and ARIPIPRAZOLE Oral Solution 3 mg / 6 mg / 12 mg Packet [SAWAI] https://www.sawai.co.jp/en/file/2018/09/20180905-02.pdf Wed, 05 Sep 2018 15:06:44 +0000 Upsher-Smith Launches Generic Version of Lomotil® (Diphenoxylate Hydrochloride and Atropine Sulfate) Tablets https://www.sawai.co.jp/en/file/2018/09/20180903-02.pdf Mon, 03 Sep 2018 10:22:50 +0000 Sawai Pharmaceutical Receives Approvals for Six Compounds with 13 Strengths of Generic Drugs https://www.sawai.co.jp/en/file/2018/08/20180816-02.pdf Thu, 16 Aug 2018 15:30:37 +0000 IR “Summary of Financial Results for the 1st Quarter of FY2018” https://www.sawai.co.jphttp://v4.eir-parts.net/v4Contents/View.aspx?template=ir_material_for_fiscal_ym&sid=51863&code=4555 Tue, 14 Aug 2018 15:07:05 +0000 IR “Financial Results for the 1st Quarter of FY2018” https://www.sawai.co.jphttp://v4.eir-parts.net/v4Contents/View.aspx?template=ir_material_for_fiscal_ym&sid=51862&code=4555 Tue, 14 Aug 2018 15:06:27 +0000